When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Apollo Endosurgery, Inc. (APEN) was already down 85% from its 2016 debut price when the pandemic cratered sales of its elective procedure-leveraged endoscopy devices.
Short on cash, the company was forced to execute a substantially dilutive secondary offering in July 2020 at $1.25 a share.
With a 3Q20 revenue rebound, a likely FDA clearance of its colonoscopy suture candidate imminent, and a one-day 77% analyst upgrade-induced rally, Apollo merited further investigation.
A full investment analysis follows in the paragraphs below.